Mutual of America Capital Management LLC Cuts Position in Mettler-Toledo International Inc. (NYSE:MTD)

Mutual of America Capital Management LLC trimmed its position in shares of Mettler-Toledo International Inc. (NYSE:MTDFree Report) by 16.2% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,701 shares of the medical instruments supplier’s stock after selling 524 shares during the period. Mutual of America Capital Management LLC’s holdings in Mettler-Toledo International were worth $3,775,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors also recently bought and sold shares of the company. Bank of New York Mellon Corp increased its holdings in shares of Mettler-Toledo International by 169.4% in the 1st quarter. Bank of New York Mellon Corp now owns 573,702 shares of the medical instruments supplier’s stock worth $763,764,000 after buying an additional 360,786 shares during the last quarter. PineStone Asset Management Inc. increased its stake in Mettler-Toledo International by 127.4% during the second quarter. PineStone Asset Management Inc. now owns 259,629 shares of the medical instruments supplier’s stock worth $362,855,000 after acquiring an additional 145,453 shares during the last quarter. Capital International Investors raised its position in Mettler-Toledo International by 15.1% during the first quarter. Capital International Investors now owns 1,075,420 shares of the medical instruments supplier’s stock valued at $1,431,696,000 after purchasing an additional 141,431 shares during the period. Putnam Investments LLC lifted its stake in shares of Mettler-Toledo International by 2,561.7% in the 4th quarter. Putnam Investments LLC now owns 67,555 shares of the medical instruments supplier’s stock valued at $81,941,000 after purchasing an additional 65,017 shares during the last quarter. Finally, Point72 Asset Management L.P. lifted its stake in shares of Mettler-Toledo International by 22,090.4% in the 4th quarter. Point72 Asset Management L.P. now owns 59,914 shares of the medical instruments supplier’s stock valued at $72,673,000 after purchasing an additional 59,644 shares during the last quarter. Institutional investors own 95.07% of the company’s stock.

Insider Activity

In other news, CFO Shawn Vadala sold 250 shares of the stock in a transaction that occurred on Wednesday, August 7th. The shares were sold at an average price of $1,401.00, for a total transaction of $350,250.00. Following the transaction, the chief financial officer now directly owns 4,914 shares in the company, valued at $6,884,514. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. In related news, CFO Shawn Vadala sold 250 shares of the company’s stock in a transaction on Wednesday, August 7th. The stock was sold at an average price of $1,401.00, for a total transaction of $350,250.00. Following the completion of the sale, the chief financial officer now directly owns 4,914 shares in the company, valued at approximately $6,884,514. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Christian Magloth sold 1,000 shares of Mettler-Toledo International stock in a transaction dated Thursday, August 15th. The shares were sold at an average price of $1,422.97, for a total value of $1,422,970.00. Following the completion of the transaction, the insider now owns 734 shares in the company, valued at approximately $1,044,459.98. The disclosure for this sale can be found here. Company insiders own 1.94% of the company’s stock.

Mettler-Toledo International Stock Down 2.6 %

Shares of NYSE:MTD opened at $1,406.11 on Monday. The business’s 50 day moving average is $1,408.63 and its 200 day moving average is $1,376.20. The stock has a market cap of $30.03 billion, a P/E ratio of 39.43, a price-to-earnings-growth ratio of 3.70 and a beta of 1.14. Mettler-Toledo International Inc. has a 52-week low of $928.49 and a 52-week high of $1,546.93.

Mettler-Toledo International (NYSE:MTDGet Free Report) last announced its quarterly earnings results on Thursday, August 1st. The medical instruments supplier reported $9.65 EPS for the quarter, beating the consensus estimate of $9.00 by $0.65. Mettler-Toledo International had a negative return on equity of 575.61% and a net margin of 20.95%. The firm had revenue of $946.75 million for the quarter, compared to analyst estimates of $929.13 million. During the same quarter last year, the firm posted $10.19 earnings per share. The business’s revenue for the quarter was down 3.6% on a year-over-year basis. On average, sell-side analysts anticipate that Mettler-Toledo International Inc. will post 40.35 EPS for the current fiscal year.

Analysts Set New Price Targets

Several analysts recently weighed in on the company. Stifel Nicolaus increased their price target on Mettler-Toledo International from $1,510.00 to $1,550.00 and gave the company a “buy” rating in a report on Monday, August 5th. Jefferies Financial Group restated an “underperform” rating and issued a $1,250.00 target price (up previously from $1,230.00) on shares of Mettler-Toledo International in a report on Monday, June 3rd. StockNews.com upgraded shares of Mettler-Toledo International from a “hold” rating to a “buy” rating in a report on Thursday, July 11th. The Goldman Sachs Group raised their price objective on shares of Mettler-Toledo International from $1,150.00 to $1,300.00 and gave the stock a “neutral” rating in a research note on Tuesday, July 9th. Finally, Wells Fargo & Company assumed coverage on Mettler-Toledo International in a research note on Tuesday, August 27th. They set an “equal weight” rating and a $1,400.00 target price on the stock. Two equities research analysts have rated the stock with a sell rating, five have given a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $1,356.25.

Get Our Latest Research Report on Mettler-Toledo International

Mettler-Toledo International Profile

(Free Report)

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.Its industrial instruments comprise industrial weighing instruments and related terminals, automatic dimensional measurement and data capture solutions, vehicle scale systems, industrial software, metal detection equipment, x-ray systems, check weighing equipment, camera-based imaging equipment, track-and-trace solutions, and product inspection systems.

Further Reading

Institutional Ownership by Quarter for Mettler-Toledo International (NYSE:MTD)

Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.